334
Views
10
CrossRef citations to date
0
Altmetric
Review

Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status

ORCID Icon, ORCID Icon, , , , , , & ORCID Icon show all
Pages 295-309 | Received 11 Feb 2019, Accepted 28 Mar 2019, Published online: 14 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marcell Csanádi, Tamas Ágh, Szabolcs Farkas-Ráduly, Blanca Gros, Christoph Tapprich, Jeremiah J Trudeau, Jeffrey H Lipton & Jonas Mattsson. (2020) Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review. Expert Review of Hematology 13:10, pages 1119-1130.
Read now
Li Hui, Li Qi, Hu Guoyu, Shen Xuliang & Tan Meiao. (2020) Ruxolitinib for treatment of steroid-refractory graft-versus-host disease in adults: a systematic review and meta-analysis. Expert Review of Hematology 13:5, pages 565-575.
Read now

Articles from other publishers (8)

Frida Schain, Constance Boissin, Tamas Laczik, Stefano Fedeli, Mats Remberger, Ola Blennow, Josefina Dykes, Torsten Eich, Christina Jones, Jonas Mattsson & Gösta Berlin. (2023) Real-world clinical characterization, healthcare resource utilization and productivity loss in chronic graft versus host patients exposed to extracorporeal photopheresis in Sweden. Transfusion and Apheresis Science 62:3, pages 103705.
Crossref
Igor Novitzky-Basso, Frida Schain, Nurgul Batyrbekova, Thomas Webb, Mats Remberger, Armand Keating & Jonas Mattsson. (2023) Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease. PLOS ONE 18:3, pages e0282753.
Crossref
Jingbo Yu, Betty K. Hamilton, James Turnbull, Susan K. Stewart, Alla Vernaya, Valkal Bhatt, Oren Meyers & John Galvin. (2022) Patient‐reported symptom burden and impact on daily activities in chronic graft‐versus‐host disease. Cancer Medicine 12:3, pages 3623-3633.
Crossref
Fan Yang, Isami Hayashi, Shinri Sato, Yumiko Saijo-Ban, Mio Yamane, Masaki Fukui, Eisuke Shimizu, Jingliang He, Shinsuke Shibata, Shin Mukai, Kazuki Asai, Mamoru Ogawa, Yuqing Lan, Qingyan Zeng, Akito Hirakata, Kazuo Tsubota & Yoko Ogawa. (2022) Eyelid blood vessel and meibomian gland changes in a sclerodermatous chronic GVHD mouse model. The Ocular Surface 26, pages 328-341.
Crossref
Freya Wenzel, Anne Pralong, Udo Holtick, Christoph Scheid, Marco Herling & Steffen T Simon. (2021) Burden and Needs of Patients with Severe GvHD from the Supportive and Palliative Care Perspective—A Literature Review. Cancers 13:11, pages 2697.
Crossref
Sandra A. Mitchell. 2021. Blood and Marrow Transplantation Long Term Management. Blood and Marrow Transplantation Long Term Management 337 348 .
Frida Schain, Nurgul Batyrbekova, Johan Liwing, Simona Baculea, Thomas Webb, Mats Remberger & Jonas Mattsson. (2020) Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease. The European Journal of Health Economics 22:1, pages 169-180.
Crossref
Jaekyung Cheon, Yoo Jin Lee, Jae-Cheol Jo, Kukju Kweon, SuJin Koh, Young Ju Min, Sang-Hyuk Park, Sin-hye Lee, Hyo-jin Kim & Yunsuk Choi. (2020) Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation. Supportive Care in Cancer 29:2, pages 975-986.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.